Fundamental Measurement: The Need Fulfilment Quality of Life (N-QOL) Measure.

N-QOL NALY Need-fulfillment quality of life need adjusted life years

Journal

Innovations in pharmacy
ISSN: 2155-0417
Titre abrégé: Innov Pharm
Pays: United States
ID NLM: 101574764

Informations de publication

Date de publication:
2021
Historique:
entrez: 4 8 2021
pubmed: 5 8 2021
medline: 5 8 2021
Statut: epublish

Résumé

The quality adjusted life year (QALY) has serious problems related to its failure to adhere to measurement theory. If a QALY is to be meaningful, the utility score that translates time spent to an equivalent time spent in so-called perfect health must have ratio properties (i.e., it must support multiplication). Multiattribute utility scores (e.g. those generated by the EQ-5D-5L) fail to meet this standard. The multiattribute instruments produce ordinal scores that lack a true zero and they generate negative values. The manifest deficiencies of multiattribute utility instruments render them unfit, not only as a measure of therapy response but also in generating QALY claims. After 30 years of belief in their use, utilities and QALYs are clearly analytical dead ends. The purpose of this commentary is to demonstrate a coherent way forward in health technology assessment by focusing, not on clinical attributes as surrogates for quality of life, but on measures that are based on a conceptual model describing patient value in terms of need-fulfilment. Building on an extensive, yet often overlooked literature, need-based measures that fit Rasch Measurement Theory criteria are converted from ordinal scores to interval scores to evaluate response to therapy. These measures meet the requirements of single attribute fundamental measurement which is the standard in the physical sciences. It is proposed that a translation from a Rasch interval scale (defined by logits) can be transformed to a bounded ratio scale. Need based Quality of Life (N-QOL) scales bounded by 0 (where no needs are fulfilled) to 1 (where all needs are fulfilled) form such scales. The N-QOL supports the full range of arithmetic operations. Multiattribute utilities and mathematically invalid QALYs can be put to one side as unfortunate historical curiosities in favor of a disease or target population specific N-QOL scale. Such a scale has the required properties to evaluate disease specific response to therapy This can also support N-QOL adjusted life years with a need- fulfillment life year (NALY) metric with ratio properties.

Identifiants

pubmed: 34345508
doi: 10.24926/iip.v12i2.3798
pmc: PMC8326693
doi:

Types de publication

Journal Article

Langues

eng

Informations de copyright

© Individual authors.

Déclaration de conflit d'intérêts

PCL is an Advisory Board member and consultant to the Patient Access and Affordability Project, a program of Patients Rising. SPM develops QoL measures for use in clinical trials and routine clinical practice.

Références

Qual Life Res. 2006 Feb;15(1):103-15
pubmed: 16411035
Innov Pharm. 2020 Nov 12;11(4):
pubmed: 34007644
Am J Alzheimers Dis Other Demen. 2020 Jan-Dec;35:1533317520951690
pubmed: 32851850
Innov Pharm. 2020 Jul 31;11(3):
pubmed: 34007635
Value Health. 2004 Sep-Oct;7 Suppl 1:S4-8
pubmed: 15367236
Curr Rheumatol Rev. 2017;13(3):197-205
pubmed: 28641552
J Appl Meas. 2018;19(3):271-282
pubmed: 30169335
Qual Life Res. 2015 Sep;24(9):2279-88
pubmed: 25702267
Arch Phys Med Rehabil. 1989 Nov;70(12):857-60
pubmed: 2818162
J Med Econ. 2019 Jun;22(6):523-530
pubmed: 30556787
J Med Econ. 2018 May;21(5):474-480
pubmed: 29514528
J Med Econ. 2019 Jun;22(6):516-522
pubmed: 30556774
Qual Life Res. 2011 Sep;20(7):1043-52
pubmed: 21312065
Health Qual Life Outcomes. 2007 Feb 02;5:7
pubmed: 17274818
F1000Res. 2020 Aug 26;9:1048
pubmed: 33093950
Health Policy. 1992 Oct;22(3):307-19
pubmed: 10122730
Value Health. 2018 Feb;21(2):119-123
pubmed: 29477388
Respir Med. 2010 May;104(5):633-43
pubmed: 20053543
Br J Dermatol. 2003 Aug;149(2):323-31
pubmed: 12932239
Clin Nutr. 2018 Jun;37(3):978-983
pubmed: 28446383

Auteurs

Paul C Langley (PC)

College of Pharmacy, University of Minnesota, Minnesota MN USA; Maimon Research, Tucson AZ USA.

Stephen P McKenna (SP)

Population Health, University of Manchester, Manchester UK; Galen Research, Manchester UK.

Classifications MeSH